We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.2B
AUM Growth
Cap. Flow
+$17.7B
Cap. Flow %
97.06%
Top 10 Hldgs %
26.4%
Holding
3,057
New
3,055
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$936M
2
AAPL icon
Apple
AAPL
+$762M
3
NVDA icon
NVIDIA
NVDA
+$739M
4
AMZN icon
Amazon
AMZN
+$480M
5
META icon
Meta Platforms (Facebook)
META
+$317M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 29.31%
2 Financials 12.14%
3 Healthcare 11.33%
4 Consumer Discretionary 10.98%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGS
2076
DELISTED
PlayAGS
AGS
$243K ﹤0.01%
+21,138
New +$219K
APLT
2077
DELISTED
Applied Therapeutics
APLT
$242K ﹤0.01%
+51,723
New +$245K
SEAT icon
2078
Vivid Seats
SEAT
$55.6M
$242K ﹤0.01%
+2,104
New +$229K
UVE icon
2079
Universal Insurance Holdings
UVE
$1.23B
$242K ﹤0.01%
+12,886
New +$251K
KALV
2080
DELISTED
KalVista Pharmaceuticals
KALV
$241K ﹤0.01%
+20,489
New +$239K
OFIX icon
2081
Orthofix Medical
OFIX
$364M
$240K ﹤0.01%
+18,134
New +$248K
ROOT icon
2082
Root
ROOT
$829M
$240K ﹤0.01%
+4,645
New +$269K
GTN icon
2083
Gray Television
GTN
$499M
$239K ﹤0.01%
+46,034
New +$269K
MCB icon
2084
Metropolitan Bank Holding Corp
MCB
$1.13B
$239K ﹤0.01%
+5,687
New +$227K
YMAB
2085
DELISTED
Y-mAbs Therapeutics
YMAB
$239K ﹤0.01%
+19,787
New +$267K
RBCAA icon
2086
Republic Bancorp
RBCAA
$1.89B
$239K ﹤0.01%
+4,457
New +$227K
CDMO
2087
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$239K ﹤0.01%
+33,448
New +$256K
ORC
2088
Orchid Island Capital
ORC
$1.26B
$239K ﹤0.01%
+28,600
New +$243K
HTB
2089
HomeTrust Bancshares
HTB
$803M
$238K ﹤0.01%
+7,929
New +$214K
HONE
2090
DELISTED
HarborOne Bancorp
HONE
$238K ﹤0.01%
+21,371
New +$219K
ACCO icon
2091
Acco Brands
ACCO
$391M
$236K ﹤0.01%
+50,294
New +$251K
LXU icon
2092
LSB Industries
LXU
$834M
$235K ﹤0.01%
+28,685
New +$251K
SRI icon
2093
Stoneridge
SRI
$207M
$234K ﹤0.01%
+14,684
New +$235K
ORIC icon
2094
Oric Pharmaceuticals
ORIC
$1.25B
$234K ﹤0.01%
+33,124
New +$297K
EYPT icon
2095
EyePoint Inc
EYPT
$365M
$234K ﹤0.01%
+26,899
New +$376K
TTI icon
2096
TETRA Technologies
TTI
$1.01B
$234K ﹤0.01%
+67,544
New +$269K
FC icon
2097
Franklin Covey
FC
$203M
$233K ﹤0.01%
+6,125
New +$230K
NTGR icon
2098
NETGEAR
NTGR
$604M
$233K ﹤0.01%
+15,202
New +$213K
OLMA icon
2099
Olema Pharmaceuticals
OLMA
$894M
$232K ﹤0.01%
+21,480
New +$233K
ABUS icon
2100
Arbutus Biopharma
ABUS
$1.01B
$232K ﹤0.01%
+75,039
New +$225K

Similar funds

Corebridge Financial's Q2 2024 Portfolio in Review

Q2 2024 is the first quarter with a 13F filing on record for Corebridge Financial, which disclosed 3,057 positions worth $18.2B. Its ten largest holdings account for 26% of the portfolio.

Its largest position is Microsoft: 2,215,349 shares worth $990M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Financials and Healthcare.

  • Corebridge Financial's largest Q2 2024 buy was Microsoft: 2,215,349 shares worth $990M.
  • Corebridge Financial's ten largest holdings make up 26% of its $18.2B portfolio in Q2 2024.
  • Corebridge Financial disclosed 3,057 positions in Q2 2024, its first 13F filing on record.

Based on Corebridge Financial's 13F filing for Q2 2024, filed 14 Aug 2024.